Feed / ABBV

AbbVie Inc.

ABBV

Healthcare · 264.99 +1.2% today

Isolated · not yet confirmedMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

AbbVie Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 15 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 26 directly disclosed connections are confirming.

Company+1.2% todayVolume comparison unavailable
Market group0 of 15 activeDrug Manufacturers - General · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Demand is diverging across products, with Elahere growing while Juvederm declines on weaker demand and unfavorable pricing.
  • R&D expenses increased 20% to $2,472 million (16% of net revenues) for the three months ended March 31, 2026 due to increased funding to support all stages of the company’s pipeline assets.

Invalidation: The isolated read changes if ABBV's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind ABBV

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

GMABGenmab A/SpartnerFeb 20, 2026

Epkinly • In May 2025, Genmab A/S (Genmab) announced positive topline results from the Phase 3 trial evaluating Epkinly plus rituximab and lenalidomide versus rituximab and lenalidomide alone in adult patients with relapsed or refractory (R/R) follicular lymp…

Depended on by

RGNX10.9% of RGNXcustomerMay 14, 2026

As of December 31, 2025 and 2024, the Company had recorded $ 10.9 million and $ 11.3 million, respectively, due from AbbVie for net reimbursement of costs incurred for activities performed under AbbVie Collaboration Agreement, which was included in other curr…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 27 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ABBV is currently a Leader in the organic co-movement group Drug Manufacturers - General. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.